Stockscreener 앱 받기
36.80
0.25%
0.09
시간 외 거래:
36.80
전일 마감가:
$36.71
열려 있는:
$36.45
하루 거래량:
319.42K
Relative Volume:
0.58
시가총액:
$1.13B
수익:
$1.37B
순이익/손실:
$47.06M
주가수익비율:
24.29
EPS:
1.5151
순현금흐름:
$150.88M
1주 성능:
+0.19%
1개월 성능:
-17.43%
6개월 성능:
-26.41%
1년 성능:
-37.53%
1일 변동 폭
$36.22
$37.58
1주일 범위
$35.91
$38.01
52주 변동 폭
$35.37
$61.25
Conmed Corp Stock (CNMD) Company Profile
명칭
Conmed Corp
전화
727-214-2974
주소
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
36.80 | 1.13B | 1.37B | 47.06M | 150.88M | 1.5151 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-06-12 | 다운그레이드 | Needham | Buy → Hold |
| 2025-04-28 | 다운그레이드 | Stifel | Buy → Hold |
| 2025-02-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-02-01 | 재확인 | Needham | Buy |
| 2023-05-22 | 개시 | CL King | Buy |
| 2023-03-27 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-03-21 | 개시 | Wells Fargo | Equal Weight |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2021-10-06 | 업그레이드 | Needham | Hold → Buy |
| 2021-07-15 | 개시 | UBS | Buy |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2019-11-26 | 다운그레이드 | Needham | Buy → Hold |
| 2019-11-12 | 개시 | JP Morgan | Overweight |
| 2019-10-31 | 재확인 | Needham | Buy |
| 2019-10-04 | 재확인 | Needham | Buy |
| 2019-08-22 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2019-04-18 | 개시 | Stifel | Buy |
| 2019-04-16 | 재확인 | Needham | Buy |
| 2019-01-23 | 재확인 | Needham | Buy |
| 2018-10-16 | 개시 | Barclays | Equal Weight |
| 2018-08-07 | 재확인 | Needham | Buy |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-04-26 | 재확인 | Needham | Buy |
| 2018-02-01 | 재확인 | Needham | Buy |
| 2017-07-27 | 재확인 | Needham | Buy |
| 2017-04-27 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2017-04-27 | 재확인 | Needham | Buy |
| 2016-11-18 | 재확인 | Needham | Buy |
| 2016-07-28 | 다운그레이드 | Leerink Partners | Outperform → Mkt Perform |
| 2016-04-28 | 재확인 | Needham | Buy |
| 2015-10-22 | 재확인 | Northland Capital | Market Perform |
모두보기
Conmed Corp 주식(CNMD)의 최신 뉴스
Micro-Tech Endoscopy to acquire Conmed gastroenterology products - MassDevice
Analysts Offer Insights on Healthcare Companies: Conmed (CNMD), Alto Neuroscience, Inc. (ANRO) and Pfizer (PFE) - The Globe and Mail
CONMED (NYSE:CNMD) Upgraded to "Hold" at Wells Fargo & Company - MarketBeat
CONMED (NYSE: CNMD) EVP granted 17,198 RSUs after award correction - Stock Titan
CONMED (NYSE: CNMD) VP granted 17,471 RSUs under 2025 incentive plan - Stock Titan
CONMED (CNMD) grants 18,563 RSUs to its general counsel Foust - Stock Titan
Executive VP at CONMED (CNMD) awarded 16,926 RSUs in corrected Form 4/A - Stock Titan
[Form 4/A] CONMED Corp Amended Insider Trading Activity - Stock Titan
Micro-Tech Endoscopy Signs Definitive Agreement to Acquire Duraclip™, Precisor®, and Optibite® Product Lines from CONMED - Yahoo! Finance Canada
Piper Sandler cuts CONMED stock rating on execution issues - Investing.com
Understanding the Setup: (CNMD) and Scalable Risk - Stock Traders Daily
Here's why you should retain CONMED stock in your portfolio now - MSN
CONMED (NYSE: CNMD) appoints Andrew Moller interim principal financial officer - Stock Titan
CONMED (CNMD) executive exercises RSUs and updates reported share holdings - Stock Titan
Here's Why You Should Retain CONMED Stock in Your Portfolio Now - Finviz
CONMED Corp. Experiences Valuation Adjustment Amidst Competitive Market Dynamics - Markets Mojo
CONMED Corp. Experiences Valuation Adjustment Amid Competitive Market Landscape - Markets Mojo
CONMED (NYSE:CNMD) Raised to Strong-Buy at Wall Street Zen - MarketBeat
Pharma News: What hedge funds are buying CONMED Corporation2025 Momentum Check & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
PacBio, CONMED, Moderna, QuidelOrtho, and Tandem Diabetes Shares Are Falling, What You Need To Know - Yahoo Finance
The Technical Signals Behind (CNMD) That Institutions Follow - Stock Traders Daily
Equity awards for CONMED (CNMD) VP Matthew Schabacker detailed in Form 4 - Stock Titan
CONMED (CNMD) HR executive awarded RSUs and stock options under 2025 plan - Stock Titan
CONMED Corp (NYSE: CNMD) treasurer awarded 5,896 RSUs - Stock Titan
CONMED (NYSE: CNMD) grants RSUs and stock options to EVP - Stock Titan
CONMED (NYSE: CNMD) EVP granted RSUs and stock options in 2026 award - Stock Titan
Equity awards granted to CONMED (CNMD) General Counsel Hollie Foust - Stock Titan
Equity grant: CONMED (CNMD) VP Corporate Controller receives 5,896 RSUs - Stock Titan
CONMED Earnings Reset Story After Strong Quarter And Higher Guidance - Yahoo Finance
CNMD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
3 Reasons CNMD is Risky and 1 Stock to Buy Instead - Yahoo Finance
Conmed (CNMD) Up 22.9% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Assessing CONMED (CNMD) Valuation After Mixed Short And Long Term Share Price Performance - simplywall.st
Director Mark Kaye converts 152 RSUs at CONMED (NYSE: CNMD) into stock - Stock Titan
Momentum Shift: Does CONMED Corporation have declining or rising EPSMarket Activity Report & Precise Swing Trade Alerts - baoquankhu1.vn
Villanova Investment Management Co LLC Acquires New Shares in CONMED Corporation $CNMD - MarketBeat
Precision Trading with Conmed Corp.Ordinary Shares (CNMD) Risk Zones - Stock Traders Daily
CONMED (NYSE:CNMD) Upgraded to "Buy" at Wall Street Zen - MarketBeat
Envestnet Asset Management Inc. Boosts Holdings in CONMED Corporation $CNMD - Defense World
Decoding Conmed Corp (CNMD): A Strategic SWOT Insight - GuruFocus
CONMED Corp SEC 10-K Report - TradingView
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now - Finviz
CONMED (NYSE:CNMD) Upgraded at Zacks Research - Defense World
A Look At CONMED (CNMD) Valuation After Earnings And Growth In Key Surgical Segments - simplywall.st
CONMED (NYSE:CNMD) Upgraded to Hold at Zacks Research - MarketBeat
5 Must-Read Analyst Questions From CONMED's Q4 Earnings Call - Finviz
5 Essential Analyst Inquiries from CONMED’s Fourth Quarter Earnings Discussion - Bitget
Earnings call transcript: CONMED Q4 2025 beats EPS forecasts, stock dips - Investing.com
Assessing CONMED (CNMD) Valuation After Q4 Results And Surgical Portfolio Shift - Yahoo Finance UK
Street Watch: Should I trade or invest in Taboolacom Ltd Equity Warrant2025 Pullback Review & Long-Term Growth Portfolio Plans - baoquankhu1.vn
CONMED Q4 Earnings Call Highlights - Defense World
Conmed Corp (CNMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):